TY  - JOUR 
AU  - Pérez-Carretero, Claudia
AU  - Hernández-Sánchez, María
AU  - González, Teresa
AU  - Quijada Álamo, Miguel
AU  - Martín Izquierdo, Marta
AU  - Santos-Mínguez, Sandra
AU  - Miguel-García, Cristina
AU  - Vidal, María-Jesús
AU  - García-De-Coca, Alfonso
AU  - Galende, Josefina
AU  - Pardal, Emilia
AU  - Aguilar, Carlos
AU  - Vargas-Pabón, Manuel
AU  - Dávila, Julio
AU  - Gascón-Y-Marín, Isabel
AU  - Hernández-Rivas, José-Ángel
AU  - Benito Sánchez, Rocío
AU  - Hernández-Rivas, Jesús-María
AU  - Rodríguez Vicente, Ana E.
PY  - 2022
UR  - http://hdl.handle.net/10366/171344
AB  - [EN]Interstitial 14q32 deletions involving IGH gene are infrequent events in chronic lymphocytic leukemia (CLL), affecting less than 5% of patients. To date, little is known about their clinical impact and molecular underpinnings, and its mutational...
LA  - eng
KW  - B-Cell
KW  - Chronic
KW  - Lymphocytic
KW  - Leukemia
KW  - Genes
KW  - Immunoglobulin Heavy Chain
KW  - Humans
KW  - Mutation
KW  - Prognosis
KW  - TNF Receptor-Associated Factor 3
KW  - Biología Molecular
KW  - Prognosis
KW  - Mutation
KW  - Leukemia
KW  - Humans
KW  - Molecular Biology
KW  - Genes
KW  - TNF Receptor-Associated Factor 3
TI  - TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
DO  - 10.1002/ajh.26578
T2  - American journal of hematology
VL  - 97
M2  - 903
ER  -